We undertook surgical bilateral lung volume reduction in 20 patients with severe chronic obstructive pulmonary disease to relieve thoracic distention and improve respiratory mechanics. The operation, done through median sternotomy, involves excision of 20% to 30% of the volume of each lung. The most affected portions are excised with the use of a linear stapling device fitted with strips of bovine pericardium attached to both the anvil and the cartridge, to buttress the staple lines and eliminate air leakage through the staple holes. Preoperative and postoperative assessment of results has included grading of dyspnoea and quality of life, exercise performance, and objective measurements of lung function by spirometry and plethysmography. There has been no early or late mortality and no requirement for immediate postoperative ventilatory assistance. Follow-up ranges from 1 to 15 months (mean 6.4 months). The mean forced expiratory volume in 1 second has improved by 82% and the reduction in total lung capacity, residual volume, and trapped gas has been highly significant. These changes have been associated with marked relief of dyspnoea and improvement in exercise tolerance and quality of life. Although the follow-up period is short, these preliminary results suggest that bilateral surgical volume reduction may be of significant value for selected patients with severe chronic obstructive pulmonary disease. (J Thorac Cardiovasc Surg 1995;109:106-19) 
The management of chronic obstructive pulmonary disease (COPD) is largely a medical problem, a fact reflected in recent international treatment guidelines."2 However, various surgical approaches to treatment have been devised, usually aimed either at improving respiratory muscle function by changes in thoracic cage volume or modifications of the underlying lung mechanics. These have included procedures as diverse as chondrectomy to mobilise the chest wall, autonomic and peripheral chemoreceptor denervation, and attempts to limit expiratory airway closing using Goretex, rectus sheath, fascia lata and plastic prostheses. These approaches have met with little success and have been abandoned. 3 Only two forms of surgery are now generally practised for patients with COPD -namely, bullectomy and lung transplantation. Although the latter procedure produces dramatic improvement in symptoms and exercise capacity, its use is limited by the availability of suitable donor organs, competition from patients with other lung diseases (who are often younger), and a recognition that chronic rejection and especially the development of obliterative bronchiolitis limits median survival to about three years. 4 The growing number of disabled patients with COPD waiting for transplantation led the St Louis group of surgeons to reconsider old options and revisit a procedure now known as lung volume reduction surgery (LVRS).5 Alternative approaches using thoracoscopic laser treatment to contract overexpanded areas of lung have been developed on the West Coast of America. In the last two years these procedures have become so widespread as to alarm US medical insurers who have asked for a moratorium on their use until further evidence of their effectiveness is available. Before reviewing the data that led to this remarkable position, it is instructive to consider what happened when bullectomy was originally developed as a procedure to improve symptoms in patients with COPD.
Surgery for bullae Bullae have been defined as emphysematous spaces larger than 1 cm in diameter in the inflated state.6 Several "types" are recognised with type 1 bullae arising in the lungs of non-smokers whilst types 2 and 3 appear to be an exaggeration of the underlying panacinar or centriacinar emphysema. 7 In this respect the use of the terms "types 3 In addition, coexisting emphysema reduces pulmonary elastic recoil and loss of alveolar attachment means that airway collapse occurs prematurely. The relative importance of these two processes -small airways disease and emphysema -continues to be debated, with some groups believing that emphysema is itself physiologically unimportant'516 while others have related the clinical pattern of particular types of emphysema to either small airways disease or a reduction in elastic recoil.'7 Bullae have always been considered a special case where particularly weakened areas of the lung have broken down and enlarged, relatively rapidly, leading to the collapse/compression of adjacent lung.'8 The resulting space ventilates so poorly that it adds little to the total dead space and so does not influence gas exchange. Whether or not bullae are under positive pressure during spontaneous breathing remains uncertain. '9 However, when their volume is sufficient, their removal/obliteration is seen to improve gas exchange and reduce pulmonary overinflation in much the same way as does draining an extrapleural pneumothorax.
Since most patients with severe COPD do not have giant bullae, surgery can have only a limited role. However, not all surgeons have accepted this and, in the 1950s, Otto Brantigan suggested that the normal circumferential pull on the airways was lost in emphysema and might be restored by downsizing the lungs. He emphasised that his operation was not designed to remove pathological tissue but was directed at the "restoration of a normal physiologic principle". Lung volumes were reduced by a "clamp and suture" method with vagotomy which had the theoretical benefit of diminishing sputum retention. His results were reported on 26 sequential patients, five of whom died. Patients underwent unilateral thoracotomy with the contralateral side being operated on at least three months later. Most of the benefit followed the first operation. The initial postoperative mortality was high at 16%, largely as a result of persisting air leaks, and objective improvement was hard to demonstrate. At this stage it appeared that conventional physiological wisdom was correct and only bullae were worth resecting.
Lung volume reduction surgery: the modern approach By the late 1980s Cooper and colleagues working in St Louis had developed the procedure of single lung transplantation for emphysema.20 They were initially worried that the transplanted lung would be much smaller than the thoracic cavity into which it was transplanted, but this did not prove to be a problem as the configuration of the chest wall rapidly adapted to the new smaller volume. Moreover, they had found that it was possible to ventilate even patients with severe emphysema satisfactorily through one lung alone. As their list of patients awaiting transplantation grew, they looked for alternatives which might give symptomatic benefit and reconsidered the ideas of Brantigan. Their selection criteria are listed in table 1. They developed a robust battery of imaging and physiological assessments before and afterwards which has led to more rigorous data collection than previously (table 2) . Their initial report in 1995 described this procedure in 20 patients with severe GOPD who were selected on the basis of a distended thorax, predominantly upper lobe disease as defined by CT breathing and the degree of intrinsic positive expiratory pressure (an indirect measure of lung hyperinflation) in eight patients were reduced immediately, and at three and six months after surgery. Further studies, particularly ofgas exchange, are clearly needed before other mechanisms relevant to explaining these benefits can be excluded. Nonetheless, successful LVRS supports the argument that emphysema does make an important contribution to the symptoms of patients with COPD and to their accompanying airflow limitation.
Are the benefits sustained? Whilst the immediate results of treatment are undoubtedly impressive, the question arises as to how long these improvements will last. At present follow up data are limited but, as the number of procedures reported is escalating rapidly, this is soon likely to change. Unfortunately, relatively few investigators have adopted the robust assessment procedure reported in table 2 which is certainly necessary if any new operation is to be evaluated properly. Moreover, it is not clear how representative or complete are the series of patients being reported compared with the total number of procedures performed. Variations in operative technique and patient selection further complicate this assessment. There are also significant differences between centres in the role 3.5r- standardised approach between two or three centres so that the particular components of treatment could be identified. The problems of research in general surgery clearly extend to the cardiothoracic field. 36 The most complete follow up data published come from St Louis.37 Thirty three patients underwent LVRS (total mortality 3%) and their functional improvements were compared postoperatively with those of 39 patients who underwent single lung transplantation (mortality 10-2%) and 25 in whom bilateral lung transplantation was performed (total mortality 16%). The ages of the patients were similar but the disease severity before surgery, as expressed spirometrically, was greater in the transplanted patients (mean FEV1 25% predicted in those who underwent LVRS compared with 15% predicted in those who underwent lung transplantation). More patients who had LVRS survived the year offollow up than did those who were transplanted, but they had shown a smaller increase in FEV1 and FVC (fig 1) . However, the six minute walking distance had increased to similar levels by one year in both those who had volume reduction and single lung transplant patients, although the best results overall were achieved by those who survived bilateral lung transplantation. 
